Successful containment of horizontal enterovirus infection in a neonatal unit in Singapore through diagnosis by polymerase chain reaction (PCR) and direct sequence analysis

Background: Enterovirus’ epidemics (EV) often coincide with seasonal peaks in the community. However, they can also occur sporadically in neonatal units. The identification of EV infection in newborns can be difficult because they tend to have light or non-specific symptoms. This study reports an EV epidemic in the neonatal unit of KK Women’s Hospital, Singapore.

Methods: This is a simple and retrospective retrospective cohort study of newborns that had positive results for EV during the epidemic. Demographic characteristics, clinical presentations and results have been analyzed. The control measures used to limit the propagation of the infection are reported.

Results: A total of 7 cases of EV infection have been identified. Their median weighing on birth and their gestational age were 1240 g (750 to 2890 g) and 28 weeks (26-35 weeks), respectively. The symptoms took place at a median age of 48 days (9-103 days). All cases initially presented with recurrent apnea and 4 necessary for the assisted fan required with CPAP (2) and mechanical ventilation (2). Serious complications have occurred in 3 infants (2 with a necroting enterocolite and 1 with meningitis) and no deceased. EV has been detected from the relevant swabs (n = 6), csf (n = 2) and nasopharyngeal (n = 2). The viral subtyping revealed an Echovirus 25. The monitoring of all infants exposed by nasopharyngeal swabs was implemented, as well as strict contact precautions and coherence measures.

Conclusions: Premature infants with EV are more subject to serious complications, which can lead to significant morbidity. Thus, early recognition of symptoms, rapid diagnosis and rapid implementation of infection control measures are essential to prevent propagation of subsequent infection.

 

Kallikreins of human tissue in polymorphic adenocarcinoma: a polymerase chain reaction and an immunohistochemical study

The polymorphic adenocarcinoma (PAC) is the second most common tumor of malignant salivary gland of minor salivary glands. The Kallikreins (KLKS) human tissues are a very preserved family of proteases expressed by various tissues and organs. The literature demonstrates a link between klks and the salivary neoplasms of the gland. The purpose of this study was to determine KLK mRNA levels in CAP tissue samples and determine whether the KLK expression is limited to tumor cells. Nineteen CAP cases were examined (1987-2013). The diagnosis has been confirmed, demographic data has been collected and samples of formulated fixed salivary tissues and fixed paraffin. RNA insulation has been achieved, followed by complementary DNA conversion through reverse transcription. By using PCR, the quantitative level of expression of KLKS1-15 has been recorded.

Samples with high and low kLK expression were selected for the coloring of immunohistochemistry. The results revealed a statistically significant increase in KLK average KLK mRNA expression for KLK1, KLK4, KLK10, KLK12 and KLK15 in PAC tissue samples, compared to normal salivary gland fabric (U Mann-Whitney U test, P <0.05). The results of immunohistochemistry have shown that KLKS was present in tumor cells. In particular, all samples demonstrating a relatively higher KLK mRNA expression showed equivalent or increased staining scores compared to low KLK mRNA expression samples. In conclusion, there appears to be an aberrant kallikrein expression in polymorphic adenocarcinoma, suggesting that the possibility of influence on Kallikrein’s waterfall on the development and progression of the tumor. Opportunine identification of etiological agents of enteric infections is necessary to reduce the burden of infantile diarrheal mortality.

The detection methods based on the amplification of the nucleic acid provide a fast and reliable way for the diagnosis of microbes in clinical samples. This study was undertaken to evaluate a conventional conventional polymeric chain reaction of conventional conventional transcription (RT-PCR) conventional (RT-PCR) transcription “developed at the Indian Council for Medical Research.

Successful containment of horizontal enterovirus infection in a neonatal unit in Singapore through diagnosis by polymerase chain reaction (PCR) and direct sequence analysis
Successful containment of horizontal enterovirus infection in a neonatal unit in Singapore through diagnosis by polymerase chain reaction (PCR) and direct sequence analysis

Double Disclosure Probes Improve the sensitivity of detection to acute respiratory syndrome Coronavirus 2 (SARS-COV-2) in a reaction of the reverse transcription polymerase chain (RT-PCR)

Background: Serious Respiratory Syndrome Coronavirus 2 (SARS-COV-2) that emerged in the city of Wuhan, Province of Hubei, China, spread all over the world and threatens human life. The detection of SARS-COV-2 is essential to prevent new epidemics, the retrocedure of the distribution of diseases and the management of patients. Currently, a reaction of the reverse transcription polymerase chain (RT-PCR) is used to detect the virus in clinical laboratories. However, although this test is considered a high specificity, its sensitivity would be as low as 60-70%. Improved sensitivity is therefore urgently required.

Methods: We used the first-handed program and a range recommended by the CDC (N1, N2 and N3) in the United States and NIID (N1 and N2) in Japan. In addition, we have designed double mess probes according to the virus sequence provided by the NIID to develop another test (called the YCH test [N1 and N2]). Using these tests, we made RT-PCR with serial diluted DNA positive controls to evaluate and compare the detection sensitivity of the three tests. In addition, 66 nasopharyngeal swabs were tested to determine diagnostic performance.

Results: The value of the RT-PCR threshold cycle (CT) was relatively small for CDC and YCH analyzes in relation to the NIID test. Serial dilution tests have shown that CDC and YCH analyzes could detect low copy numbers of the positive control of DNA. The starting background fluorescence signal was lower for the YCH test compared to the NIID test. We evaluated the diagnostic performance between single probes (NIID) and double incorrect (YCH) using 66 nasopharyngeal buffers. When the results of the YCH-N2 analysis were used as a reference, each test has detected SARS-COV-2 with 56% positive percentage agreements for NIID-N1, 61% for YCH-N1 and 94% for NIID -N2, and 100% of negative agreements for NIID-N1, YCH-N1 and NIID-N2.

COX IV Antibody

AF6725 100ul
EUR 420

COX IV Antibody

49275-100ul 100ul
EUR 399.6

COX IV Antibody

49275-50ul 50ul
EUR 286.8

Cox-3 Antibody

3687-100
EUR 379.2

Cox-3 Antibody

3687-30T
EUR 175.2

Cox-1 Antibody

3361-100
EUR 379.2

Cox-1 Antibody

3361-30T
EUR 175.2

Cox-2 Antibody

3362R-100
EUR 379.2

Cox-2 Antibody

3362R-30T
EUR 175.2

Cox-4 Antibody

3638-100
EUR 405.6

Cox-4 Antibody

3638-30T
EUR 175.2

Cox 1 antibody

20R-1525 100 ug
EUR 807.6
Description: Rabbit polyclonal Cox 1 antibody

Cox 2 antibody

20R-1526 100 ug
EUR 807.6
Description: Rabbit polyclonal Cox 2 antibody

Cox 4 antibody

20R-1683 100 ug
EUR 807.6
Description: Rabbit polyclonal Cox 4 antibody

Cox 3 antibody

20R-1705 100 ug
EUR 807.6
Description: Rabbit polyclonal Cox 3 antibody

COX IV antibody

ABF5468 100 ug
EUR 525.6

COX-2 Antibody

R34884-100UG 100 ug
EUR 399

Protein S100-A16 (S100A16) Antibody

20-abx121969
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Protein S100-A16 (S100A16) Antibody

20-abx115360
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Protein S100-A16 (S100A16) Antibody

20-abx126506
  • EUR 493.20
  • EUR 710.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 50 ul

Protein S100-A16 (S100A16) Antibody

20-abx014753
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Protein S100-A16 (S100A16) Antibody

20-abx310213
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein S100-A16 (S100A16) Antibody

abx237558-100ug 100 ug
EUR 610.8

Human Coxsackievirus A16 (CV-A16) IgM Rapid Test Kit

abx092087-20tests 20 tests
EUR 393.6

Monoclonal PTGS2 / COX2 / COX-2 Antibody (clone COX 229), Clone: COX 229

AMR09628G 0.1ml
EUR 580.8
Description: A Monoclonal antibody against Human PTGS2 / COX2 / COX-2 (clone COX 229). The antibodies are raised in Mouse and are from clone COX 229. This antibody is applicable in IHC-P, IHC-Fr

COX-1

MO15113 100 ug
EUR 459.6

COX-2

GT15206 100 ug
EUR 631.2

COX-2

RA18005 100 ul
EUR 666

Enterovirus Coxsakievirus A16 Protein

abx061531-100ug 100 ug
EUR 1212

Mediana A16 Battery Pack

SAF0464 EACH
EUR 527.82

Mediana A16 Soft Bag

SAF0466 EACH
EUR 112.86

Inactivated Coxsackievirus A16 Antigen

VAng-Lsx0079-1mL 1 mL
EUR 700.8
Description: Coxsackievirus A16, natural antigen.

Cox-1 Polyclonal Antibody

ABP51033-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Cox-1 from Human. This Cox-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-1 at AA range: 520-600

Cox-1 Polyclonal Antibody

ABP51033-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Cox-1 from Human. This Cox-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-1 at AA range: 520-600

Cox-1 Polyclonal Antibody

ABP51033-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Cox-1 from Human. This Cox-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-1 at AA range: 520-600

Cox-2 Polyclonal Antibody

ABP51035-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Cox-2 from Human. This Cox-2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-2 at AA range: 530-610

Cox-2 Polyclonal Antibody

ABP51035-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Cox-2 from Human. This Cox-2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-2 at AA range: 530-610

Cox-2 Polyclonal Antibody

ABP51035-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Cox-2 from Human. This Cox-2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Cox-2 at AA range: 530-610

COX IV Conjugated Antibody

C49275 100ul
EUR 476.4

COX IV Monoclonal Antibody

EM1032-100ul 100ul
EUR 334.8
Description: A Mouse Monoclonal antibody against COX IV from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IF

COX IV Monoclonal Antibody

EM1032-50ul 50ul
EUR 248.4
Description: A Mouse Monoclonal antibody against COX IV from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IF

Cox-1 Polyclonal Antibody

ES2032-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against Cox-1 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Cox-1 Polyclonal Antibody

ES2032-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against Cox-1 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA

Cox-2 Polyclonal Antibody

ES2034-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against Cox-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Cox-2 Polyclonal Antibody

ES2034-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against Cox-2 from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Cox-1 Polyclonal Antibody

40780-100ul 100ul
EUR 302.4

Cox-1 Polyclonal Antibody

40780-50ul 50ul
EUR 224.4

Cox-2 Polyclonal Antibody

40781-100ul 100ul
EUR 302.4

Cox-2 Polyclonal Antibody

40781-50ul 50ul
EUR 224.4

COX-4 Antibody (Biotin)

abx445406-100ug 100 ug
EUR 693.6

COX-4 Antibody (FITC)

abx445407-100ug 100 ug
EUR 678

COX-4 Antibody (HRP)

abx445408-100ug 100 ug
EUR 678

Anti-Cox-2 Antibody

A00084-1 100uL
EUR 546
Description: Rabbit Polyclonal antibody for PTGS2, COX2 detection. Tested positive for ELISA,Immunohistochemistry,Western Blot, in human, mouse, rat

Monoclonal COX IV Antibody

APG02703G 0.1ml
EUR 580.8
Description: A Monoclonal antibody against Human COX IV. The antibodies are raised in Mouse. This antibody is applicable in WB, ICC, IP, FC

Polyclonal Cox-2 Antibody

APG02704G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cox-2 . This antibody is tested and proven to work in the following applications:

Polyclonal Cox-4 Antibody

APG02705G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cox-4 . This antibody is tested and proven to work in the following applications:

Polyclonal Cox-1 Antibody

APR00081G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cox-1 . This antibody is tested and proven to work in the following applications:

Polyclonal Cox-3 Antibody

APR00168G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cox-3 . This antibody is tested and proven to work in the following applications:

COX IV Polyclonal Antibody

EA150-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against COX IV from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC

COX IV Polyclonal Antibody

EA150-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against COX IV from Human/ Rat/ Mouse. This antibody is tested and validated for WB, ELISA, IHC

Anti-COX-2 antibody

STJ160093 1 mL C
EUR 1026

Anti-COX-2 antibody

STJ180081 0.1 ml
EUR 274.8

Anti-COX-2 antibody

STJ180353 0.1 ml
EUR 279.6

Anti-COX IV antibody

STJ96935 200 µl
EUR 236.4
Description: COX IV is a protein encoded by the COX4I1 gene which is approximately 19,5 kDa. COX IV is localised to the mitochondrion inner membrane. It is involved in respiratory electron transport, metabolism, gene expression, cardiac muscle contraction, apoptosis and autophagy. It is the terminal enzyme of the mitochondrial respiratory chain and forms a multi-subunit enzyme complex that couples the transfer of electrons from cytochrome c to molecular oxygen and contributes to a proton electrochemical gradient across the inner mitochondrial membrane. COX IV is expressed ubiquitously in human tissue. Mutations in the COX4I1 gene may result in Calvarial hyperostosis. STJ96935 was developed from clone 6C8 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. This antibody detects endogenous COX IV protein.

Anti-Cox-1 antibody

STJ92432 200 µl
EUR 236.4
Description: Rabbit polyclonal to Cox-1.

Anti-Cox-2 antibody

STJ92438 200 µl
EUR 236.4
Description: Cox-2 is a protein encoded by the PTGS2 gene which is approximately 68,9 kDa. Cox-2 is localised to the endoplasmic reticulum membrane. It is involved in PEDF induced signalling, arachidonic acid metabolism, aspirin triggered resolvin E biosynthesis and cytokine signalling. It is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. Cox-2 is expressed in cytokines and mitogens. Mutations in the PTGS2 gene may result in colorectal adenoma and chronic pain. STJ92438 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of Cox-2 protein.

Anti-COX IV antibody

STJ99044 200 µl
EUR 236.4
Description: Mouse monoclonal to COX IV.

COX IV Polyclonal Antibody

A71590-050 50 ul
EUR 302.5

COX IV Polyclonal Antibody

A71590-100 100 ul
EUR 423.5

COX IV Polyclonal Antibody

A71590
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

Human S100-A16 Antibody (Biotin Conjugate)

30255-05121 150 ug
EUR 442.8

Protein S100-A16 (S100A16) Antibody (HRP)

20-abx310214
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein S100-A16 (S100A16) Antibody (FITC)

20-abx310215
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Protein S100-A16 (S100A16) Antibody (Biotin)

20-abx310216
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Coxsackie A16 (G10 Strain) Protein

abx069781-1ml 1 ml
EUR 610.8

Human S100-A16 AssayLite Antibody (FITC Conjugate)

30255-05141 150 ug
EUR 513.6

Human S100-A16 AssayLite Antibody (RPE Conjugate)

30255-05151 150 ug
EUR 513.6

Human S100-A16 AssayLite Antibody (APC Conjugate)

30255-05161 150 ug
EUR 513.6

Human S100-A16 AssayLite Antibody (PerCP Conjugate)

30255-05171 150 ug
EUR 565.2

S100 Calcium Binding Protein A16 (S100A16) Antibody

20-abx103779
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

S100 Calcium Binding Protein A16 (S100A16) Antibody

20-abx174446
  • EUR 1095.60
  • EUR 560.40
  • 1 mg
  • 200 ug

S100 Calcium Binding Protein A16 (S100A16) Antibody

20-abx130127
  • EUR 543.60
  • EUR 159.60
  • EUR 1562.40
  • EUR 744.00
  • EUR 410.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

S100 Calcium Binding Protein A16 (S100A16) Antibody

abx332824-100ul 100 ul
EUR 510

S100 Calcium Binding Protein A16 (S100A16) Antibody

20-abx330190
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

COX-1 Peptide

45-124P 0.1 mg
EUR 405.6
Description: (CT) COX1 / COX-1 Peptide

COX-2 Peptide

45-125P 0.1 mg
EUR 405.6
Description: (CT) COX2 / COX-2 Peptide

anti-COX IV

YF-PA11035 50 ug
EUR 435.6
Description: Mouse polyclonal to COX IV

anti-COX IV

YF-PA11036 100 ug
EUR 483.6
Description: Rabbit polyclonal to COX IV

anti-COX IV

YF-PA23493 50 ul
EUR 400.8
Description: Mouse polyclonal to COX IV

Phospho-COX IV (Ser58) Antibody

AF3725 100ul
EUR 540

Cox-1 Polyclonal Conjugated Antibody

C40780 100ul
EUR 476.4

Cox-2 Polyclonal Conjugated Antibody

C40781 100ul
EUR 476.4

COX-2 (2G1) Monoclonal Antibody

EM1339-100ul 100ul
EUR 334.8
Description: A Mouse Monoclonal antibody against COX-2 (2G1) from Human/ Mouse/ Rat. This antibody is tested and validated for IHC

COX-2 (2G1) Monoclonal Antibody

EM1339-50ul 50ul
EUR 248.4
Description: A Mouse Monoclonal antibody against COX-2 (2G1) from Human/ Mouse/ Rat. This antibody is tested and validated for IHC

Anti-COX IV/COX4I1 Antibody

A05442-1 100ug/vial
EUR 400.8

Cox IV Loading Control Antibody

A0017-001 100ul
EUR 542.4

Antibody for Human COX-4

SPC-688D 0.1mg
EUR 424.8
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is unconjugated.

Antibody for Human COX-4

SPC-688D-A390 0.1mg
EUR 481.2
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 390.

Antibody for Human COX-4

SPC-688D-A488 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 488.

Antibody for Human COX-4

SPC-688D-A565 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 565.

Antibody for Human COX-4

SPC-688D-A594 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 594.

Antibody for Human COX-4

SPC-688D-A633 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 633.

Antibody for Human COX-4

SPC-688D-A655 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 655.

Antibody for Human COX-4

SPC-688D-A680 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 680.

Antibody for Human COX-4

SPC-688D-A700 0.1mg
EUR 480
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to ATTO 700.

Antibody for Human COX-4

SPC-688D-ALP 0.1mg
EUR 472.8
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Alkaline Phosphatase.

Antibody for Human COX-4

SPC-688D-APC 0.1mg
EUR 478.8
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to APC .

Antibody for Human COX-4

SPC-688D-APCCY7 0.1mg
EUR 565.2
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to APC/Cy7.

Antibody for Human COX-4

SPC-688D-BI 0.1mg
EUR 475.2
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Biotin.

Antibody for Human COX-4

SPC-688D-DY350 0.1mg
EUR 496.8
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Dylight 350.

Antibody for Human COX-4

SPC-688D-DY405 0.1mg
EUR 483.6
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Dylight 405.

Antibody for Human COX-4

SPC-688D-DY488 0.1mg
EUR 471.6
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Dylight 488.

Antibody for Human COX-4

SPC-688D-DY594 0.1mg
EUR 474
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Dylight 594.

Antibody for Human COX-4

SPC-688D-DY633 0.1mg
EUR 468
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Dylight 633.

Antibody for Human COX-4

SPC-688D-FITC 0.1mg
EUR 470.4
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to FITC.

Antibody for Human COX-4

SPC-688D-HRP 0.1mg
EUR 465.6
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to HRP.

Antibody for Human COX-4

SPC-688D-P594 0.1mg
EUR 488.4
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to PE/ATTO 594.

Antibody for Human COX-4

SPC-688D-PCP 0.1mg
EUR 478.8
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to PerCP.

Antibody for Human COX-4

SPC-688D-RPE 0.1mg
EUR 476.4
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to RPE .

Antibody for Human COX-4

SPC-688D-STR 0.1mg
EUR 477.6
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is conjugated to Streptavidin.

Antibody for Human COX-4

SPC-688S 0.012mg
EUR 78
Description: A polyclonal antibody for COX-4 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with human synthetic peptide of Human COX-4. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This COX-4 antibody is unconjugated.

Antibody for Human COX IV

SPC-1320D 0.1ml
EUR 376.8
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is unconjugated.

Antibody for Human COX IV

SPC-1320D-A390 0.1ml
EUR 433.2
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 390.

Antibody for Human COX IV

SPC-1320D-A488 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 488.

Antibody for Human COX IV

SPC-1320D-A565 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 565.

Antibody for Human COX IV

SPC-1320D-A594 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 594.

Antibody for Human COX IV

SPC-1320D-A633 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 633.

Antibody for Human COX IV

SPC-1320D-A655 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 655.

Antibody for Human COX IV

SPC-1320D-A680 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 680.

Antibody for Human COX IV

SPC-1320D-A700 0.1ml
EUR 432
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to ATTO 700.

Antibody for Human COX IV

SPC-1320D-ALP 0.1ml
EUR 426
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to Alkaline Phosphatase.

Antibody for Human COX IV

SPC-1320D-APC 0.1ml
EUR 430.8
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to APC .

Antibody for Human COX IV

SPC-1320D-APCCY7 0.1ml
EUR 518.4
Description: A polyclonal antibody for COX IV from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human A synthesized peptide derived from human COX IV. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:2000), IHC (1:200), ICC/IF (1:500). This COX IV antibody is conjugated to APC/Cy7.

Conclusion: Double-discarded probes decreased the bottom fluorescence and improved the RT-PCR detection sensitivity for SARS-COV-2.